Ovid Therapeutics, Inc. (OVID)
2.62
+0.32
(+13.91%)
USD |
NASDAQ |
Mar 20, 16:00
2.62
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Research and Development Expense (Quarterly) : 6.554M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | 133.13M |
| CytomX Therapeutics, Inc. | 20.76M |
| Artelo Biosciences, Inc. | 0.893M |
| Eton Pharmaceuticals, Inc. | 1.78M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |